Literature DB >> 18258452

Molecular mass analysis of antibodies by on-line SEC-MS.

Lowell J Brady1, John Valliere-Douglass, Theresa Martinez, Alain Balland.   

Abstract

Mass analysis of recombinant protein therapeutics is an important assay for product characterization. Intact mass analysis is used to provide confirmation of proper translation of the DNA sequence and to detect the presence of post-translational modifications such as amino acid processing and glycosylation. We present here a method for the rapid mass analysis of antibodies using a polyhydroxyethyl aspartamide column operated in size-exclusion mode and coupled with ESI-MS. This method allows extremely efficient desalting of proteins under acidic conditions that are optimal for subsequent mass analysis using standard ESI conditions. Furthermore, this technique is significantly faster and more sensitive than rpHPLC methods, typically considered the standard chromatography approach for mass analysis of proteins. This method is flexible and robust, and should prove useful for applications where a combination of speed and sensitivity are required.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18258452     DOI: 10.1016/j.jasms.2007.12.006

Source DB:  PubMed          Journal:  J Am Soc Mass Spectrom        ISSN: 1044-0305            Impact factor:   3.109


  16 in total

1.  Effect of enzyme inhibitors on protein quaternary structure determined by on-line size exclusion chromatography-microelectrospray ionization mass spectrometry.

Authors:  M L Shen; L M Benson; K L Johnson; J J Lipsky; S Naylor
Journal:  J Am Soc Mass Spectrom       Date:  2001-01       Impact factor: 3.109

2.  Rapid method for monitoring galactosylation levels during recombinant antibody production by electrospray mass spectrometry with selective-ion monitoring.

Authors:  H Z Wan; S Kaneshiro; J Frenz; J Cacia
Journal:  J Chromatogr A       Date:  2001-04-13       Impact factor: 4.759

3.  Improving mass accuracy of high performance liquid chromatography/electrospray ionization time-of-flight mass spectrometry of intact antibodies.

Authors:  Himanshu S Gadgil; Gary D Pipes; Thomas M Dillon; Michael J Treuheit; Pavel V Bondarenko
Journal:  J Am Soc Mass Spectrom       Date:  2006-04-21       Impact factor: 3.109

4.  Development of an analytical reversed-phase high-performance liquid chromatography-electrospray ionization mass spectrometry method for characterization of recombinant antibodies.

Authors:  Thomas M Dillon; Pavel V Bondarenko; Margaret Speed Ricci
Journal:  J Chromatogr A       Date:  2004-10-22       Impact factor: 4.759

5.  Non-enzymatic hinge region fragmentation of antibodies in solution.

Authors:  Armando J Cordoba; Bao-Jen Shyong; Deirdre Breen; Reed J Harris
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2005-04-25       Impact factor: 3.205

6.  Characterization of a novel modification to monoclonal antibodies: thioether cross-link of heavy and light chains.

Authors:  Guillermo I Tous; Ziping Wei; Jinhua Feng; Susanna Bilbulian; Stephen Bowen; Jaime Smith; Robert Strouse; Patrick McGeehan; Jose Casas-Finet; Mark A Schenerman
Journal:  Anal Chem       Date:  2005-05-01       Impact factor: 6.986

7.  Analysis of the composition of immunoconjugates using size-exclusion chromatography coupled to mass spectrometry.

Authors:  Alexandru C Lazar; Lintao Wang; Walter A Blättler; Godfrey Amphlett; John M Lambert; Wei Zhang
Journal:  Rapid Commun Mass Spectrom       Date:  2005       Impact factor: 2.419

8.  Hydrophilic-interaction chromatography for the separation of peptides, nucleic acids and other polar compounds.

Authors:  A J Alpert
Journal:  J Chromatogr       Date:  1990-01-19

9.  Effects of anions on the positive ion electrospray ionization mass spectra of peptides and proteins.

Authors:  U A Mirza; B T Chait
Journal:  Anal Chem       Date:  1994-09-15       Impact factor: 6.986

10.  Accumulation of succinimide in a recombinant monoclonal antibody in mildly acidic buffers under elevated temperatures.

Authors:  Grace C Chu; Dirk Chelius; Gang Xiao; Hui K Khor; Sururat Coulibaly; Pavel V Bondarenko
Journal:  Pharm Res       Date:  2007-03-24       Impact factor: 4.580

View more
  9 in total

1.  Analysis of reduced monoclonal antibodies using size exclusion chromatography coupled with mass spectrometry.

Authors:  Hongcheng Liu; Georgeen Gaza-Bulseco; Chris Chumsae
Journal:  J Am Soc Mass Spectrom       Date:  2009-08-28       Impact factor: 3.109

2.  Rapid identification of an antibody DNA construct rearrangement sequence variant by mass spectrometry.

Authors:  Rebecca A Scott; Rich Rogers; Alain Balland; Lowell J Brady
Journal:  MAbs       Date:  2014       Impact factor: 5.857

3.  Utility of Ion Mobility Mass Spectrometry for Drug-to-Antibody Ratio Measurements in Antibody-Drug Conjugates.

Authors:  Richard Y-C Huang; Ekaterina G Deyanova; David Passmore; Vangipuram Rangan; Shrikant Deshpande; Adrienne A Tymiak; Guodong Chen
Journal:  J Am Soc Mass Spectrom       Date:  2015-06-30       Impact factor: 3.109

Review 4.  Advances and challenges in analytical characterization of biotechnology products: mass spectrometry-based approaches to study properties and behavior of protein therapeutics.

Authors:  Igor A Kaltashov; Cedric E Bobst; Rinat R Abzalimov; Guanbo Wang; Burcu Baykal; Shunhai Wang
Journal:  Biotechnol Adv       Date:  2011-05-17       Impact factor: 14.227

5.  Size Exclusion Chromatography-Ion Mobility-Mass Spectrometry Coupling: a Step Toward Structural Biology.

Authors:  Guillaume Van der Rest; Frédéric Halgand
Journal:  J Am Soc Mass Spectrom       Date:  2017-09-20       Impact factor: 3.109

6.  Mass spectrometric analysis of intact human monoclonal antibody aggregates fractionated by size-exclusion chromatography.

Authors:  Başak Kükrer; Vasco Filipe; Esther van Duijn; Piotr T Kasper; Rob J Vreeken; Albert J R Heck; Wim Jiskoot
Journal:  Pharm Res       Date:  2010-08-03       Impact factor: 4.200

7.  Native size-exclusion chromatography-mass spectrometry: suitability for antibody-drug conjugate drug-to-antibody ratio quantitation across a range of chemotypes and drug-loading levels.

Authors:  Jay Jones; Laura Pack; Joshua H Hunter; John F Valliere-Douglass
Journal:  MAbs       Date:  2020 Jan-Dec       Impact factor: 5.857

8.  Assessing analytical methods to monitor isoAsp formation in monoclonal antibodies.

Authors:  Catherine M Eakin; Amanda Miller; Jennifer Kerr; James Kung; Alison Wallace
Journal:  Front Pharmacol       Date:  2014-04-29       Impact factor: 5.810

Review 9.  Glycan analysis of therapeutic glycoproteins.

Authors:  Lei Zhang; Shen Luo; Baolin Zhang
Journal:  MAbs       Date:  2015-11-24       Impact factor: 5.857

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.